Cancer Immunotherapy May Be Bolstered via New Treg-Suppressing MechanismGenetic Engineering & Biotechnology NewsMessing with a dual-purpose protein that can both stimulate and modulate antitumor immunity would seem a tricky way to try enhancing cancer … Continue reading
Multiple sclerosis: Oligodendrocytes from stem cellsEurekAlert (press release)A scientific collaboration between stem cell researchers of the Heinrich-Heine-University led by Prof. Küry (Dept. of Neurology) and by Prof. Adjaye (Institute for Stem Cell … Continue reading
From Dr. Jekyll to Mr. Hyde of cancer immunotherapyEurekAlert (press release)An international research team led by the University Hospitals of Magdeburg and Bonn has now discovered a previously unrecognized braking mechanism that limits the efficacy of… Continue reading
From Dr. Jekyll to Mr. Hyde of cancer immunotherapyEurekAlert (press release)An international research team led by the University Hospitals of Magdeburg and Bonn has now discovered a previously unrecognized braking mechanism that limits the efficacy of… Continue reading
From Dr. Jekyll to Mr. Hyde of cancer immunotherapyEurekAlert (press release)An international research team led by the University Hospitals of Magdeburg and Bonn has now discovered a previously unrecognized braking mechanism that limits the efficacy of… Continue reading
|
Agilent launches new SureGuide CRISPR activation and interference libraries
Zenopa Agilent Technologies has announced the launch of new SureGuide pooled libraries for CRISPR activation and interference. The latest additions to the company’s range of pooled SureGuide CRISPR libraries for functional genomics will be created using … |